Suppr超能文献

测定 EIS 复合物的瞬变期及研究 L-阿拉伯糖对健康成年人血糖水平的抑制作用。

Determination of the transient period of the EIS complex and investigation of the suppression of blood glucose levels by L-arabinose in healthy adults.

机构信息

Research & Development Laboratory, Sanwa Cornstarch Co. Ltd., 594 Unate, Kashihara-shi, Nara Pref 634-8585, Japan.

出版信息

Eur J Nutr. 2011 Sep;50(6):447-53. doi: 10.1007/s00394-010-0154-3. Epub 2010 Dec 17.

Abstract

PURPOSE

L-Arabinose uncompetitively inhibits intestinal sucrase by forming an enzyme-inhibitor-substrate (EIS) complex. The transient period of the EIS complex affects the time span of inhibition. We determined the apparent transient period of the EIS complex of sucrase, L-arabinose, and sucrose both in vitro and in humans.

METHODS

Intestinal acetone powder (a source of sucrase), L-arabinose, and sucrose were mixed and injected into a dialysis membrane that was placed in a sucrose solution. The production rate of D-glucose and the release rate of L-arabinose from sucrase were determined. We also investigated the suppression of blood glucose levels by L-arabinose in 21 healthy volunteers. Sucrose (40 g) was ingested with or without L-arabinose (2 g), then blood glucose values were measured, which returned to steady-state conditions within 2 h. Volunteers were then given 90 g of commercial adzuki bean jelly containing 40 g sucrose as the sucrose load, and blood glucose values were measured again.

RESULTS

Addition of L-arabinose reduced the production rate of D -glucose compared to the rates measured in the absence of L-arabinose for several hours in vitro. L-Arabinose was released at a lower rate in the presence of sucrose than in its absence. Blood glucose values measured 2 h after sucrose was given with L -arabinose were significantly lower than those measured when L-arabinose was not given (Δ change in maximum value: with L-arabinose, 53.8 ± 19.7 mg/dL; without L-arabinose, 65.0 ± 17.7 mg/dL).

CONCLUSION

The EIS complex of sucrase-L -arabinose-sucrose was maintained for several hours both in vitro and in humans.

摘要

目的

L-阿拉伯糖通过形成酶-抑制剂-底物(EIS)复合物来非竞争性抑制肠道蔗糖酶。EIS 复合物的暂态期会影响抑制的时间跨度。我们分别在体外和人体内测定了蔗糖酶、L-阿拉伯糖和蔗糖的 EIS 复合物的表观暂态期。

方法

将肠丙酮粉(蔗糖酶的来源)、L-阿拉伯糖和蔗糖混合后注入置于蔗糖溶液中的透析膜内。测定 D-葡萄糖的生成速率和蔗糖酶中 L-阿拉伯糖的释放速率。我们还研究了 21 名健康志愿者摄入 L-阿拉伯糖对血糖水平的抑制作用。志愿者摄入 40 g 蔗糖,同时摄入或不摄入 2 g L-阿拉伯糖,然后测量血糖值,2 h 内血糖值恢复至稳态。志愿者随后摄入含有 40 g 蔗糖的 90 g 商用红豆果冻作为蔗糖负荷,再次测量血糖值。

结果

体外数小时内,与未添加 L-阿拉伯糖时相比,添加 L-阿拉伯糖可降低 D-葡萄糖的生成速率。与未添加蔗糖时相比,在存在蔗糖时 L-阿拉伯糖的释放速率较低。给予蔗糖并同时摄入 L-阿拉伯糖 2 h 后测量的血糖值明显低于未摄入 L-阿拉伯糖时(最大变化值的差值:有 L-阿拉伯糖时,53.8±19.7 mg/dL;无 L-阿拉伯糖时,65.0±17.7 mg/dL)。

结论

体外和体内 EIS 复合物的蔗糖酶-L-阿拉伯糖-蔗糖复合物均能维持数小时。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验